Amp, this situation with Idenix reinforces that Wall Street hates them. The real value of IDIX, as measured buy the Merck offer is $3.85 billion. With the hate that Wall Street brought upon them they didn't trade anywhere close to that value. The HATE was working. It follows that if Ariad is experiencing the same HATE, it could command an above normal premium in a buyout. I have just recently decided that I would accept a $20.50 ($3.85 billion/186 million shares) buyout. How about it Dr. Berger? Bring it on.
News 
Market Data 
Discover 
